{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:55:21Z","timestamp":1778784921295,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.transci.2019.102681","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T02:23:15Z","timestamp":1574734995000},"page":"102681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Can we better predict delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease?"],"prefix":"10.1016","volume":"59","author":[{"given":"Brian D.","family":"Adkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deva","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quentin","family":"Eichbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.transci.2019.102681_bib0005","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.transci.2019.102681_bib0010","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/ajh.24537","article-title":"A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease","volume":"91","author":"Mekontso Dessap","year":"2016","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.transci.2019.102681_bib0015","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ajh.24908","article-title":"Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease","volume":"92","author":"Narbey","year":"2017","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.transci.2019.102681_bib0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/ehm.09.2","article-title":"Hyperhemolysis syndrome in sickle cell disease","volume":"2","author":"Win","year":"2009","journal-title":"Expert Rev Hematol"},{"issue":"11","key":"10.1016\/j.transci.2019.102681_bib0025","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.5858\/arpa.2017-0251-RS","article-title":"Hyperhemolysis syndrome in patients with sickle cell disease","volume":"142","author":"Banks","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.transci.2019.102681_bib0030","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.13494","article-title":"How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease","volume":"170","author":"Gardner","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.transci.2019.102681_bib0035","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.4081\/hr.2017.6934","article-title":"A fatal case of immune hyperhemolysis with bone marrow necrosis in a patient with sickle cell disease","volume":"9","author":"Karafin","year":"2017","journal-title":"Hematol Rep"},{"key":"10.1016\/j.transci.2019.102681_bib0040","series-title":"Tietz textbook of clinical chemistry and molecular diagnostics.","author":"Rifai","year":"2018"},{"issue":"April 4","key":"10.1016\/j.transci.2019.102681_bib0045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1537-2995.1997.37497265338.x","article-title":"The sickle cell hemolytic transfusion reaction syndrome","volume":"37","author":"Petz","year":"1997","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.transci.2019.102681_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002095","article-title":"Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain","volume":"3","author":"Taylor","year":"2008","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.transci.2019.102681_bib0055","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1182\/blood.V126.23.4595.4595","article-title":"Hyperhaemolysis in sickle cell disease is not necessarily a transfusion reaction","volume":"126","author":"Jones","year":"2015","journal-title":"Blood"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219302460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219302460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:50:03Z","timestamp":1761468603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050219302460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1473050219302460"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2019.102681","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can we better predict delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease?","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2019.102681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102681"}}